Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

January 15, 2006 (Vol. 26, No. 2)

French Biotech on the Upturn

  • There was a new mood of optimism about French biotech at the recent 9th European Biotech Crossroads meeting in Lille. The reason was that France recently had its first biotech IPOs since 1999 with the float on Euronext of ExonHit Therapeutic (www.exonhit.com) and BioAlliance Pharma (www.bioalliancepharma.com). As well ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.